Sort by
Refine Your Search
-
Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description As a joint venture of the University of Basel and the University
-
Your position You will develop generative models on single-cell and spatial genomics data, from sequencing and imaging, and apply them to human developmental and disease biology. Possible research
-
Your position This project addresses that limitation by designing ultrasmall nanoparticles suitable for intravenous delivery and tumor targeting, with a specific focus on neuroblastoma. Building
-
We offer you Interdisciplinary work in a highly collaborative environment A unique environment combining state-of-the-art ultrafast experiments at University of Applied Sci-ences and Arts Northwestern Switzerland with state-of-the-art experiments in quantum optics at University of Basel Close...
-
Building a quantum computer that can solve real-world problems will require the integration of many highly coherent qubits. Hole-spin qubits in planar germanium quantum wells are among the most promising candidates for this goal, combining fast electrical control, compact device geometry, and...
-
The research group Ecology at the Department of Environmental Sciences at the University of Basel in Switzerland invites applications for a PhD position within the ERC project 'Global status
-
Your position You will work on the development of a nanopore-based platform for single-molecule analysis of nanoclusters. Your research will include: • Establishing nanopore assays for detecting and
-
properties. Your position In this project, we exploit circuit quantum electrodynamics (cQED) techniques based on high-impedance superconducting resonators in the GHz regime to probe electron-electron
-
Your position We aim to pursue a new interdisciplinary approach, combining the synthesis of multi-functional culture-matrices with cell-instructive viscoelastic properties, in-depth cell
-
Your position Despite the success of EBV-specific T-cell therapies in selected malignancies, therapeutic efficacy remains limited in tumors expressing only a restricted repertoire of viral antigens